Tag Archives: price target

Big time losers and the reasons why (WILL, SON, JCI)

Posted on January 20, 2012 by Martin Timble

In this report: Whiting Petroleum (NYSE:WILL), Sonoco Products Company (NYSE:SON) and Johnson Controls (NYSE:JCI).

Whiting Petroleum (NYSE:WILL) shares are trading over 5 percent lower today after the company reduced its fourth quarter and 2012 production estimates which led to analysts …

Posted in Latest Headlines, Reports | Tagged adjusted, budget, Buy, capital, earnings, expenditure, JCI, Johnson Controls, JP Morgan, Needham, NYSE, NYSE:JCI, NYSE:SON, NYSE:WILL, price target, production, quarter, rating, RW Baird, shares, SON, Sonoco Products Company, Whiting Petroleum, WILL | Comments Off

Big time losers and the reasons why (KUTV, COOL, GEN)

Posted on January 18, 2012 by Martin Timble

In this report: Ku6 Media (NASDAQ:KUTV), Majesco Entertainment Company (NASDAQ:COOL) and GenOn Energy (NYSE:GEN).

Ku6 Media (NASDAQ:KUTV) shares are seeing a correction today after rallying by more than 136 percent on Tuesday. The surge came after the company announced that …

Posted in Latest Headlines, Reports | Tagged adjusted, Analysts, Coal, company, COOL, costs, CSAPR, downgrade, firm, fiscal, forecast, GEN, GenOn Energy, Google, Ku6 Media, KUTV, Majesco Entertainment Company, NASDAQ, NASDAQ:COOL, NASDAQ:KUTV, NYSE, NYSE:GEN, operating, price target, profit, quarter, report, results, revenue, sell, shares, UBS, youtube | Comments Off

Tuesday’s mixed bag of stocks (CLDX, AKRX, AMAT)

Posted on January 17, 2012 by Cameron White

In this report: Celldex Therapeutics (NASDAQ:CLDX), Akorn (NASDAQ:AKRX) and Applied Materials (NASDAQ:AMAT).

Celldex Therapeutics (NASDAQ:CLDX) gained more than 17 percent on Tuesday after the company announced the initiation of it Phase 1 clinical trial of its hematopoietic growth factor, CDX-301. …

Posted in Latest Headlines, Main Post | Tagged Akorn, AKRX, AMAT, analyst, Applied Materials, Buy, Celldex Therapeutics, CLDX, company, develop, earn, expectations, firm, fiscal, growth, NASDAQ, NASDAQ:AKRX, NASDAQ:AMAT, NASDAQ:CLDX, price target, profit, rating, RBC Capital, revenue, Roth Capital, share, tech, upgrade | Comments Off

Big time losers and the reasons why (NVS, JDAS, AKAM)

Posted on January 13, 2012 by Cameron White

In this report: Novartis (NYSE:NVS), JDA Software (NASDAQ:JDAS) and Akamai Technologies (NASDAQ:AKAM).

Novartis (NYSE:NVS) shares have dropped 1.7 percent so far today after the company announced that it will cut 1,960 jobs in the U.S. this year in order to …

Posted in Latest Headlines, Reports | Tagged AKAM, Akamai Technologies, analyst, Buy, company, DA Davidson, downgrade, earnings, firm, forecasted, JDA Software, JDAS, NASDAQ, NASDAQ:AKAM, NASDAQ:JDAS, Novartis, NVS, NYSE:NVS, patent, price target, profit, quarter, rating, report, restructuring, results, revenue, stock | Comments Off

Soaring stocks and the reasons why (DKS, SINA, TAYD)

Posted on January 12, 2012 by Cameron White

In this report: Taylor Devices (NASDAQ:TAYD), Dick’s Sporting Goods (NYSE:DKS) and Sina Corporation (NASDAQ:SINA).

Taylor Devices (NASDAQ:TAYD) shares jumped 14 percent today after the company reported its second quarter financials. The company reported net income during the three month period …

Posted in Latest Headlines, Reports | Tagged Analysts, company, Dick’s Sporting Goods, DKS, earnings, financials, firm, guidance, JP Morgan, NASDAQ, NASDAQ:SINA, NASDAQ:TAYD, net income, NYSE, NYSE:DKS, outlook, price target, profit, report, revenue, sales, shares, SINA, Sina Corporation, stock, TAYD, Taylor Devices, upgrade | Comments Off

What the fuss Chevron, Cree and 99 Cents Only Stores?

Posted on January 12, 2012 by Martin Timble

In this report: 99 Cents Only Stores (NYSE:NDN), Chevron (NYSE:CVX) and Cree (NASDAQ:CREE).

99 Cents Only Stores (NYSE:NDN) is trading fairly flat today after the company reported its third quarter sales after the markets closed on Wednesday. The discount retailer …

Posted in Latest Headlines, Reports | Tagged 99 Cents Only Stores, analyst, business, Buy, Chevron, company, Cree, CVX, earnings, expectations, financials, margin, marketing, markets, NASDAQ, NASDAQ:CREE, NDN, NYSE, NYSE:CVX, NYSE:NDN, price target, prodction, profit, quarter, rating, refining, report, retailer, revenue, saes, sell, stores, trading | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.